These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 32697953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast.
    Yan Q, Machalz D, Zöllner A, Sorensen EJ, Wolber G, Bureik M.
    Biochem Pharmacol; 2017 Dec 15; 146():174-187. PubMed ID: 28951277
    [Abstract] [Full Text] [Related]

  • 3. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T.
    Int Rev Cytol; 2007 Dec 15; 260():35-112. PubMed ID: 17482904
    [Abstract] [Full Text] [Related]

  • 4. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
    Zhang M, Rottschäfer V, C M de Lange E.
    Drug Metab Rev; 2024 Feb 15; 56(1):1-30. PubMed ID: 38126313
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.
    Batt AM, Magdalou J, Vincent-Viry M, Ouzzine M, Fournel-Gigleux S, Galteau MM, Siest G.
    Clin Chim Acta; 1994 May 15; 226(2):171-90. PubMed ID: 7923812
    [Abstract] [Full Text] [Related]

  • 7. Functional expression and activity screening of all human cytochrome P450 enzymes in fission yeast.
    Durairaj P, Fan L, Du W, Ahmad S, Mebrahtu D, Sharma S, Ashraf RA, Liu J, Liu Q, Bureik M.
    FEBS Lett; 2019 Jun 15; 593(12):1372-1380. PubMed ID: 31111477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast.
    Sharma SS, Sharma S, Zhao J, Bureik M.
    Biomedicines; 2023 Jan 19; 11(2):. PubMed ID: 36830817
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
    Lee B, Ji HK, Lee T, Liu KH.
    Drug Metab Dispos; 2015 Jul 19; 43(7):1137-46. PubMed ID: 25904760
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
    Zhong S, Han W, Hou C, Liu J, Wu L, Liu M, Liang Z, Lin H, Zhou L, Liu S, Tang L.
    AAPS J; 2017 Jan 19; 19(1):203-214. PubMed ID: 27681103
    [Abstract] [Full Text] [Related]

  • 15. Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout mice.
    Zheng H, Wang L, Zeng S, Chen J, Wang H, Yu J, Gong X, Jiang H, Yang X, Qi X, Wang Y, Lu L, Hu M, Zhu L, Liu Z.
    Biopharm Drug Dispos; 2018 Jul 19; 39(7):344-353. PubMed ID: 30016542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Production of ibuprofen acyl glucosides by human UGT2B7.
    Buchheit D, Dragan CA, Schmitt EI, Bureik M.
    Drug Metab Dispos; 2011 Dec 19; 39(12):2174-81. PubMed ID: 21862693
    [Abstract] [Full Text] [Related]

  • 19. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
    Lee SY, Lee JY, Kim YM, Kim SK, Oh SJ.
    Toxicol Lett; 2015 Jun 01; 235(2):107-15. PubMed ID: 25835148
    [Abstract] [Full Text] [Related]

  • 20. Hepatic Metabolism of Sakuranetin and Its Modulating Effects on Cytochrome P450s and UDP-Glucuronosyltransferases.
    Jeong H, Lee J, Kim S, Yeo YY, So H, Wu H, Song YS, Jang CY, Kim HD, Kim MJ, Chang M.
    Molecules; 2018 Jun 26; 23(7):. PubMed ID: 29949932
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.